KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug Pharmaceutical Investing
IMV Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA Across Five Solid Tumor Indications Biotech Investing
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease Biotech Investing
Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer Pharmaceutical Investing
European Commission Approves Merck’s KEYTRUDA (pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC Pharmaceutical Investing
Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing Pharmaceutical Investing
